Antiviral Drug Market Industry Analysis and Forecast (2021-2027) Trends, Dynamics, Statistics, Segmentation by Drug Class, Drug Type and Application and region

Antiviral Drug Market size was valued at US$ 61.80 Bn. in 2020 and the total revenue is expected to grow at CAGR 4.2% through 2021 to 2027, reaching nearly US$ 82.43 Bn.

Antiviral Drug Market Overview:

Antiviral drugs are used to treat viral infections and act by inhibiting their target viruses. The growth of antiviral drug market is driven by a factor such as a rise in healthcare expenditure, growing research and development investment. The emergence of life treating diseases like bird flu, strong development pipeline, and increasing incidence rates of viral infections particularly HIV. In 2019 WHO estimates that approximately, 36.7 million people are suffering from HIV/AIDS worldwide with 1.1 million deaths of AIDS-related illnesses. Thanks to government initiatives towards awareness about HIV-like infection, it’s also contributing to the growth of the market. Antiviral Drug Market To know about the Research Methodology :- Request Free Sample Report 2020 is a considered as a base year to forecast the market from 2021 to 2027. 2020’s market size is estimated on real numbers and outputs of the key players and major players across the globe. Past five years trends are considered while forecasting the market through 2027. 2020 is a year of exception and analyzed specially with the impact of lockdown by region. Antiviral Drug Market Dynamics: The increasing prevalence of viral infections such as HIV, influenza, herpes, hepatitis, and other viral infections, as well as developments in antiviral drug R&D, rising strategic initiatives for the antiviral drugs market, and developing healthcare infrastructure in emerging economies, are all major drivers boosting the global antiviral drugs treatment market. Over the forecast period, a primary element driving demand for antiviral medications is the rising incidence of viral illness over the world. According to the WHO, an estimated 325 million individuals worldwide have hepatitis, with 71 million of these having chronic hepatitis C virus infection. Furthermore, the United States Department of Health and Human Services estimates that 2.4 million people in the country have hepatitis C, with approximately 850,000 people infected with hepatitis B. Antiviral medications are being developed as a result of research and development in the field of viral illnesses. Increased investment in the field of antiviral medications, owing to its multiple benefits, has resulted in the emergence of new chances for laboratory research. Antiviral medications help to shorten the duration of flu symptoms and are recommended for both flu therapy and prevention. The medications may also lower the incidence of consequences such as antibiotic-resistant respiratory infections in children, ear infections in adults, and hospitalization in adults. The rising number of HIV cases around the world is a primary factor driving market revenue growth. According to the World Health Organization (WHO), approximately 34.7 million people will be infected with HIV by 2020. Antiviral Drug Market Segment Analysis: The Antiviral Drug Market is segmented based on Drug Class Drug Type and Application. Based on the Drug Class, The Antiviral Drug Market is segmented into DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, The Reverse Transcriptase Inhibitors segment is dominated the market and held the largest market share of 49.0% in the year 2020. Increasing the diagnosis and treatment rate of HIV cases, as this medicine is mainly used to treat HIV infection and high effectiveness of these drugs against viral infections rising the market growth. Antiviral Drug Market Based on the Drug Type, The Antiviral Drug Market is segmented into Branded Generics. The branded segment dominated the Antiviral Drug Market and held the largest market share of 57.2% in the year 2020. The high adoption rate of branded drugs in North America and the European markets and the high cost of drugs is expected to drive the segment. Based on the Application, The Antiviral Drug Market is segmented into HIV, Hepatitis, Herpes, Influenza, Others. The HIV segment dominated the market with the largest market share of 44.6% in the year 2020. The high prevalence of HIV infection and its treatment has been rising the demand for the branded drugs in the market. Government initiatives and drug development technology also increase the treatment rate and are estimated to drive the Antiviral Drug Market.

Antiviral Drug Market Regional Insights:

North America dominated the Antiviral Drug Market with the largest market share of 53 % in 2020. It is also expected to register a CAGR of 4.1% during the forecast period. Increase in prevalence of neurological disease and increasing geriatric population, because this disease mostly occurs in the old age people. The loss of market exclusivity for branded pharmaceuticals, rising vaccination rates against viral diseases, and government initiatives to lower the frequency of viral infections are all contributing to the market downturn. For example, the United States government is adopting a number of steps, including investing in infectious disease programs and boosting R&D initiatives for novel viral infection medicines. Presence of well-established healthcare infrastructure and favorable government initiatives for the healthcare system. The presence of high drug development technology and skilled professionals has been increased the Antiviral Drug Market in this region. Asia Pacific is expected to grow the market with a CAGR of 3.9% during the forecast period. As rising disposable income level and the favorable healthcare government initiative in emerging economies such as India, China, and Japan. Rising government funding and support to improve drug development and innovative technology in it are also increasing the market revenue in this region.Antiviral Drug MarketThe objective of the report is to present a comprehensive analysis of the Antiviral Drug Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also helps in understanding the Antiviral Drug Market dynamic, structure by analyzing the market segments and project the Antiviral Drug Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Antiviral Drug Market make the report investor’s guide.

Antiviral Drug Market Scope: Inquire before buying

Antiviral Drug Market

Antiviral Drug Market, by Region

• North America • Europe • Asia Pacific • South America • Middle East and Africa

Antiviral Drug Market Key Players

• Hoffmann-La Roche Ltd. • GlaxoSmithKline plc • AbbVie • Merck & Co., Inc. • Johnson & Johnson Services, Inc. • Bristol-Myers Squibb Company • Cipla Inc. • Aurobindo Pharma • Dr. Reddy’s Laboratories Ltd. • GlaxoSmithKline PLC • Eisai Co. Ltd. • Pfizer Inc. • Medtronic PLC • UCB SA • NeuroPace Inc. • GW Pharmaceuticals PLC • Novartis AG • Johnson & Johnson Services Inc. • Abbott Laboratories • DiaGenic ASA • Quanterix

Frequently Asked Questions:

1] Which segments are covered in Antiviral Drug Market report? Ans. The segments covered in Antiviral Drug Market report are based on by Drug Class Drug Type and Application. 2] Which region is expected to hold the highest share in the Epilepsy Treatment Market? Ans. North America is expected to hold the highest share in the Antiviral Drug Market 3] What is the market size of Antiviral Drug Market by 2027? Ans. The market size of Antiviral Drug Market by 2027 is US $ 82.43Mn. 4] Who are the top key players in the Antiviral Drug Market? Ans. Hoffmann-La Roche Ltd. GlaxoSmithKline plc, Abbie, Merck & Co., Inc., Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company, Cipla Inc., Aurobindo Pharma, bDr. Reddy’s Laboratories Ltd., GlaxoSmithKline PLC, Eisai Co. Ltd., Pfizer Inc., Medtronic PLC 5] What was the market size of Antiviral Drug Market in 2020? Ans. The market size of Antiviral Drug Market in 2020 was US $ 61.80 Mn
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Antiviral Drug Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2020 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Antiviral Drug Market 3.4. Geographical Snapshot of the Antiviral Drug Market , By Manufacturer share 4. Antiviral Drug Market Overview, 2020-2027 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Antiviral Drug Market 5. Supply Side and Demand Side Indicators 6. Antiviral Drug Market Analysis and Forecast, 2020-2027 6.1. Antiviral Drug Market Size & Y-o-Y Growth Analysis. 7. Antiviral Drug Market Analysis and Forecasts, 2020-2027 7.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 7.1.1. DNA Polymerase Inhibitors 7.1.2. Reverse Transcriptase Inhibitors 7.1.3. Protease Inhibitors 7.1.4. Neuraminidase Inhibitors 7.1.5. Others 7.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 7.2.1. Branded 7.2.2. Generics 7.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 7.3.1. HIV 7.3.2. Hepatitis 7.3.3. Herpes 7.3.4. Influenza 7.3.5. Other 8. Antiviral Drug Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2020-2027 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Antiviral Drug Market Analysis and Forecasts, 2020-2027 9.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 9.1.1. DNA Polymerase Inhibitors 9.1.2. Reverse Transcriptase Inhibitors 9.1.3. Protease Inhibitors 9.1.4. Neuraminidase Inhibitors 9.1.5. Others 9.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 9.2.1. Branded 9.2.2. Generics 9.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 9.3.1. HIV 9.3.2. Hepatitis 9.3.3. Herpes 9.3.4. Influenza 9.3.5. Other 10. Drug Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2020-2027 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Antiviral Drug Market Analysis and Forecasts, 2020-2027 11.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 11.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 11.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 12. Canada Antiviral Drug Market Analysis and Forecasts, 2020-2027 12.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 12.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 12.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 13. Mexico Antiviral Drug Market Analysis and Forecasts, 2020-2027 13.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 13.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 13.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 14. Europe Antiviral Drug Market Analysis and Forecasts, 2020-2027 14.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 14.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 14.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 15. Europe Antiviral Drug Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2020-2027 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Antiviral Drug Market Analysis and Forecasts, 2020-2027 16.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 16.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 16.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 17. France Antiviral Drug Market Analysis and Forecasts, 2020-2027 17.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 17.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 17.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 18. Germany Antiviral Drug Market Analysis and Forecasts, 2020-2027 18.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 18.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 18.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 19. Italy Antiviral Drug Market Analysis and Forecasts, 2020-2027 19.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 19.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 19.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 20. Spain Antiviral Drug Market Analysis and Forecasts, 2020-2027 20.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 20.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 20.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 21. Sweden Antiviral Drug Market Analysis and Forecasts, 2020-2027 21.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 21.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 21.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 22. CIS Countries Antiviral Drug Market Analysis and Forecasts, 2020-2027 22.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 22.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 22.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 23. Rest of Europe Antiviral Drug Market Analysis and Forecasts, 2020-2027 23.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 23.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 23.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 24. Asia Pacific Antiviral Drug Market Analysis and Forecasts, 2020-2027 24.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 24.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 24.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 25. Asia Pacific Antiviral Drug Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates &Forecast By Country, 2020-2027 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Antiviral Drug Market Analysis and Forecasts, 2020-2027 26.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 26.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 26.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 27. India Antiviral Drug Market Analysis and Forecasts, 2020-2027 27.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 27.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 27.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 28. Japan Antiviral Drug Market Analysis and Forecasts, 2020-2027 28.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 28.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 28.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 29. South Korea Antiviral Drug Market Analysis and Forecasts, 2020-2027 29.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 29.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 29.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 30. Australia Antiviral Drug Market Analysis and Forecasts, 2020-2027 30.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 30.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 30.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 31. ASEAN Antiviral Drug Market Analysis and Forecasts, 2020-2027 31.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 31.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 31.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 32. Analysis and Forecasts, 2020-2027 32.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 32.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 32.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 33. Middle East Africa Antiviral Drug Market Analysis and Forecasts, 2020-2027 33.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 33.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 33.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 34. Middle East Africa Antiviral Drug Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2020-2027 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Antiviral Drug Market Analysis and Forecasts, 2020-2027 35.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 35.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 35.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 36. GCC Countries Antiviral Drug Market Analysis and Forecasts, 2020-2027 36.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 36.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 36.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 37. Egypt Antiviral Drug Market Analysis and Forecasts, 2020-2027 37.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 37.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 37.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 38. Nigeria Antiviral Drug Market Analysis and Forecasts, 2020-2027 38.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 38.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 38.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 39. Rest of ME&A Antiviral Drug Market Analysis and Forecasts, 2020-2027 39.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 39.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 39.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 40. South America Antiviral Drug Market Analysis and Forecasts, 2020-2027 40.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 40.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 40.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 41. South America Antiviral Drug Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2020-2027 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Antiviral Drug Market Analysis and Forecasts, 2020-2027 42.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 42.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 42.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 43. Argentina Antiviral Drug Market Analysis and Forecasts, 2020-2027 43.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 43.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 43.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 44. Rest of South America Antiviral Drug Market Analysis and Forecasts, 2020-2027 44.1. Market Size (Value) Estimates & Forecast By Drug Class , 2020-2027 44.2. Market Size (Value) Estimates & Forecast By Drug Type , 2020-2027 44.3. Market Size (Value) Estimates & Forecast By Application , 2020-2027 44.4. Geographic Footprint of Major Players in the Antiviral Drug Market 44.5. Competition Matrix 44.5.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 44.5.2. New Product Launches and Product Enhancements 44.5.3. Market Consolidation 44.5.3.1. M&A by Regions, Investment and Verticals 44.5.3.2. M&A, Forward Integration and Backward Integration 44.5.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 44.6. Company Profile : Key Players 44.6.1. GlaxoSmithKline 44.6.1.1. Company Overview 44.6.1.2. Financial Overview 44.6.1.3. Geographic Footprint 44.6.1.4. Product Portfolio 44.6.1.5. Business Strategy 44.6.1.6. Recent Developments 44.6.2. AbbVie 44.6.3. Merck & Co., Inc. 44.6.4. Johnson & Johnson Services, Inc. 44.6.5. Bristol-Myers Squibb Company 44.6.6. Cipla Inc. 44.6.7. Aurobindo Pharma 44.6.8. Dr. Reddy’s Laboratories Ltd. 44.6.9. GlaxoSmithKline PLC 44.6.10. Eisai Co. Ltd. 44.6.11. Pfizer Inc. 44.6.12. Medtronic PLC 45. Primary Key Insights

About This Report

Report ID 124585
Category Healthcare
Published Date Oct 2021
Updated Date
Contact Us